OverviewChartNewsTraderScreen

UBS Knock-Out AMGN/  DE000UH50NR0  /

Frankfurt Zert./UBS
2024-06-25  3:46:30 PM Chg.+0.070 Bid4:01:01 PM Ask4:01:01 PM Underlying Strike price Expiration date Option type
1.400EUR +5.26% 1.390
Bid Size: 250,000		 1.410
Ask Size: 250,000		 Amgen Inc 172.8667 USD 2078-12-31 Call
GlobeNewswire 4:00 PM Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
TeleTrader 06-24 US closes mostly lower, as energy, banking stocks take lead
GlobeNewswire 06-20 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 06-19 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 06-18 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 06-17 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 06-17 Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 05-30 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 05-28 US markets turn to losses, Dow plunges 330 points
TeleTrader 05-28 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 05-28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 05-27 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 05-23 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-22 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 05-21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 05-21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire 05-21 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
TeleTrader 05-16 FDA approves Amgen's small cell lung cancer drug
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 05-14 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...